GCP
VBIV

GSA Capital Partners’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

GSA Capital Partners’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,815
Closed -$441K – 1986
2022
Q3 		$441K Sell
20,815
-1,420
-6% -$38.3K 0.06% 666
2022
Q2 		$539K Buy
22,235
+18,389
+478% +$626K 0.08% 453
2022
Q1 		$192K Buy
3,846
+179
+5% +$8.85K 0.03% 1179
2021
Q4 		$257K Buy
+3,667
New +$309K 0.03% 1043
2021
Q3 		– Sell
-6,259
Closed -$629K – 1849
2021
Q2 		$629K Buy
6,259
+2,122
+51% +$207K 0.07% 490
2021
Q1 		$386K Sell
4,137
-140
-3% -$14.2K 0.06% 490
2020
Q4 		$353K Buy
4,277
+1,614
+61% +$138K 0.06% 653
2020
Q3 		$228K Buy
+2,663
New +$310K 0.04% 924

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return